REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr.Ozclinics Sp. z o.o. (Poland)

Main Activities: Offices of Dentists
Full name: Dr.Ozclinics Sp. z o.o. Profile Updated: August 16, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Dr.Ozclinics Sp. z o.o. is a company based in Poland, with its head office in Warsaw. It operates in the Offices of Dentists sector. The company was established on September 03, 2021. From the latest financial highlights, Dr.Ozclinics Sp. z o.o. reported a net sales revenue increase of 18.88% in 2023. A growth of 84.12% was recorded in its total assets. The net profit margin of Dr.Ozclinics Sp. z o.o. decreased by 28.32% in 2023.

Headquarters
Ul. Alternatywy 7/U5
Warsaw; Mazowieckie; Postal Code: 02-775

Contact Details: Purchase the Dr.Ozclinics Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Dr.Ozclinics Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Dr.Ozclinics Sp. z o.o. report to view the information.
Incorporation Date:
September 03, 2021
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
94.79%
Company Performance
Financial values in the chart are available after Dr.Ozclinics Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
18.88%
Total operating revenue
18.88%
Operating profit (EBIT)
-46.48%
EBITDA
-40.56%
Net Profit (Loss) for the Period
-47.08%
Total assets
84.12%
Total equity
50.85%
Operating Profit Margin (ROS)
-30.84%
Net Profit Margin
-28.32%
Return on Equity (ROE)
-62.38%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?